Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Non-Current Assets (2023 - 2025)

Historic Non-Current Assets for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to $60.0 million.

  • Beta Bionics' Non-Current Assets changed N/A to $60.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $196.7 million, marking a year-over-year change of. This contributed to the annual value of $16.7 million for FY2024, which is 16050.79% up from last year.
  • Beta Bionics' Non-Current Assets amounted to $60.0 million in Q3 2025.
  • In the past 5 years, Beta Bionics' Non-Current Assets registered a high of $76.1 million during Q1 2025, and its lowest value of $6.4 million during Q4 2023.
  • Moreover, its 3-year median value for Non-Current Assets was $43.9 million (2025), whereas its average is $40.6 million.
  • Examining YoY changes over the last 5 years, Beta Bionics' Non-Current Assets showed a top increase of 16050.79% in 2024 and a maximum decrease of 16050.79% in 2024.
  • Over the past 3 years, Beta Bionics' Non-Current Assets (Quarter) stood at $6.4 million in 2023, then surged by 160.51% to $16.7 million in 2024, then soared by 258.93% to $60.0 million in 2025.
  • Its last three reported values are $60.0 million in Q3 2025, $43.9 million for Q2 2025, and $76.1 million during Q1 2025.